Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 14 (6) , 555-561
- https://doi.org/10.1023/a:1007410707801
Abstract
Injection drug use (IDU) is one of the most significant risk factors for viral hepatitis (B, D and C) and human immunodeficiency virus (HIV) infection. However, there is little information about the...Keywords
This publication has 21 references indexed in Scilit:
- Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus InfectionNew England Journal of Medicine, 1996
- Correlates of Hepatitis C Virus Infections among Injection Drug UsersMedicine, 1995
- Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patientsEuropean Journal of Epidemiology, 1995
- Prevalence of hepatitis C antibodies in clinical health-care workersThe Lancet, 1994
- Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index casesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Low risk of sexual transmission of hepatitis C virusJournal of Medical Virology, 1993
- A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in AmsterdamEuropean Journal of Epidemiology, 1993
- Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnelJournal of Hepatology, 1992
- A Long-Term Study of Hepatitis C Virus Replication in Non-A, Non-B HepatitisNew England Journal of Medicine, 1991
- HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAINThe Lancet, 1989